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Karyoplasts were prepared from B82 cells (thymidine kinase deficient mouse L cells) by cytochalasin B me- 
diated enucleation. Morphological measurements show that the nucleus constitutes 89% of a karyoplast by 
volume. Homokaryons were obtained by Sendai virus mediated karyoplast-B82 cell fusion. Transplanted 
nuclei were not destroyed catastrophically but were maintained intracellularly for at least 140 h. Trans- 
planted nuclear proteins were degraded with an average half-life of 84 f 7 h by processes partially sensitive 
to inhibition by NH&l (50%) and leupeptin (30%). The data therefore suggest hat some nuclear proteins 
are translocated to the cytoplasm for lysosomal degradation. 
Karyoplast; Protein degradation; Cell nucleus; Lysosome; (L cell) 
1. INTRODUCTION 2. MATERIALS AND METHODS 
Most previous degradation studies on nuclear 
proteins have concentrated on establishing the 
rates of degradation of specific classes of proteins, 
e.g. histones [l]; non-histone chromosomal pro- 
teins [2]; high-mobility group proteins 1 and 2 
[3,4]. There are few data on the pathways involved 
in the degradation of nuclear proteins. This study 
attempted to determine if there are any 
translocative vents involved in the degradation of 
nuclear proteins (cf. [5]). Our approach was to 
transplant radiolabelled nuclei into unlabelled 
cells. To transplant a functional nucleus into cells, 
karyoplasts, i.e. nuclei surrounded by a thin rim of 
cytoplasm, enclosed by plasma membrane [6-lo] 
were used as vectors. Nuclei were microinjected in- 
to recipient cells by karyoplast-cell fusion 
mediated by Sendai virus. 
2.1. Karyoplast preparation and transplantation 
Karyoplasts were prepared from B82 cells (a 
thymidine kinase deficient L cell subclone) and 
fused to B82 cells as described in [7]. 3 h post fu- 
sion, the growth medium from the culture dishes 
was removed, the cells were washed twice with 
2 ml Ca*+/Mg*+ free phosphate buffered saline 
(PBS) to remove unfused karyoplasts and dead 
cells, and 3 ml growth medium was added to each 
dish. This point was taken as zero time (to) in all 
experiments. 
2.2. Measurement of karyoplast cytoplasm 
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B82 cells were dual labelled as follows: 
cytoplasm was labelled with 1 pm latex beads 
(Sigma, Poole, Dorset, England) [8] and cell 
plasma membranes were then labelled with fluores- 
cein isothiocyanate as described by Russell and 
Mayer [ 111. Both transplanted dual labelled 
karyoplasts and cells were cultured on sterile 
coverslips. Coverslips were collected over 72 h, 
and processed as before [ 111. The number of beads 
Published by Elsevier Science Publishers B. V. (Biomedical Division) 
00145793/87/$3.50 0 1987 Federation of European Biochemical Societies 165 
Volume 210, number 2 FEBS LETTERS January 1987 
in each fluorescent cell was counted 24 h after 
plating out. This was the earliest ime at which the 
cells were sufficiently flattened out to allow the 
number of beads per cell to be precisely 
determined. 
For autoradiographic measurements, trans- 
planted, L-[3H]leucine labelled karyoplasts were 
cultured on sterile coverslips. Coverslips were col- 
lected over 140 h and processed for autoradio- 
graphy according to standard techniques and 
photographed with a Zeiss standard microscope. 
Cells and karyoplasts were prepared for electron 
microscopy as described in [ 121. Photomicro- 
graphs were taken with a Philips 410 electron 
microscope. 
2.3. Measurement of whole cell and transplanted 
nuclear protein degradation 
Cells were grown for 36 h in growth medium 
(Dulbecco’s modified Eagles medium sup- 
plemented with 10% newborn calf serum, 
100 pug/ml streptomycin, and 100 U/ml penicillin 
G) containing only 0.1 mM L-leucine and 
1 &i/ml L-[3H]leucine (spec. act. 63 Ci/mmol, 
Amersham, Bucks, England). The radiolabelled 
cells were either enucleated and the karyoplasts 
fused to unlabelled B82 cells to measure the 
degradation of transplanted nuclear proteins, or 
they were subcultured to measure endogenous pro- 
tein degradation. In either case cells were plated 
out in growth medium supplemented with 10 mM 
leucine to minimize isotope reutilization and wash- 
ed as described above. All measurements of cell 
and growth medium trichloroacetic acid-soluble 
and -insoluble radioactivity were made as de- 
scribed in [ 111. 
3. RESULTS 
3.1. Transplantation of B82 karyoplasts 
The karyoplast preparation had a purity of 95% 
as determined by analysis of karyoplasts cultured 
for 72 h [7]. 24 h after transplantation of 
karyoplasts prepared from L-[3H]leucine labelled 
cells into unlabelled cells, between 10 and 15% 
of the total initial radioactivity was retained as cell- 
associated trichloroacetic acid-insoluble radioac- 
tivity (10 experiments), indicating that stable 
transplantation was between 10 and 15% efficient. 
The amount of cytoplasm co-transplanted with 
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the karyoplast nucleus was measured in order to 
determine the usefulness of this technique for 
measuring the degradation of nuclear proteins. 
Electron micrographs of karyoplasts (30) and cells 
(20) were taken at random and the cytoplasmic and 
nuclear volumes determined with a MOP Kontron 
image analyser. The cytoplasm constitutes only 
11% of the karyoplast volume. A similar value was 
obtained from the latex bead distribution in 
homokaryons. Therefore the decrease in cell 
trichloroacetic acid-insoluble radioactivity (table 
1) represents predominantly the degradation of 
nuclear proteins in B82 homokaryons. 
Autoradiographs of transplanted B82 homo- 
karyons show that only 4.4% of the radiolabelled 
nuclei 24 h post fusion are in contaminating 
mononucleate cells (table 1) and that the silver 
grains are concentrated over the transplanted 
nucleus in the homokaryons. Few silver grains 
were observed over the cytoplasm, or the unla- 
belled nuclei in the homokaryons for up to 140 h. 
Quantitative analysis of the autoradiographs (table 
la) at intervals after fusion shows that con- 
taminating whole cells divide whilst the 
homokaryons do not divide and are therefore 
quiescent. Sendai virus does not affect the 
degradation of endogenous or microinjected pro- 
Table 1 
Quantitative examination of autoradiographs 
Time (h) post fusion 
(a) Mononucleate Homokaryons 
cells (Yo) (%o) 
24 4.4 95.6 
48 8.1 91.9 
72 16.9 83.1 
(b) Number of homokaryons 
in 65 fields 
15 157 
48 174 
140 184 
(a) Mononucleate cells and homokaryons with at least 
one radiolabelled nucleus as a percentage of the total 
number of radiolabelled cells observed. (b) The number 
of labelled homokaryons in 65 microscope fields does 
not alter with time. The apparent increase from tr5 to f48 
is due to a greater ease of counting at the latter time 
because the cells have flattened out 
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teins [2-41 except by fusing cells and forming 
quiescent homokaryons. Thus table 2a shows that 
the rate of endogenous protein degradation in- 
creased 30% after treatment of cells with Sendai 
virus as in a normal fusion [7], commensurate with 
the proportion of homokaryons produced by the 
fusion. Table lb shows that the transplanted nuclei 
in B82 homokaryons are stable over 140 h, i.e. the 
transplanted nuclei are not catastrophically 
destroyed. 
Table 2 
Average half-life of transplanted karyoplast and 
metabolically labelled protein in B82 cells 
Cell growth condition Protein half-life (h) 
(a) Metabolically labelled 
cell protein 
growing 
growing, treated with 
Sendai virus as for a 
fusion 
confluent 
161 f 6 ( 2) 
130 
66 2 8 ( 3) 
(b) Transplanted karyoplast 
protein 
transplanted 84 + 7 (10) 
transplanted + 
10 mM N&Cl 169 f 25 ( 3) 
transplanted + 0.2 mM 
leupeptin 103 
Half-lives are calculated from the loss of cell 
trichloroacetic acid-insoluble radioactivity over 120 h. 
Each determination of protein half-life involved the 
analysis of six time points (to to trzo) in triplicate. The 
errors (calculated as SD) were less than 10% of the 
mean. When the half-life was determined more than 
once, the half-life is expressed as the mean f SD of all 
available values, with the number of determinations in 
parentheses. Drugs, if included, were present at the 
concentration stated for the 120 h of the experiments. 
Cell death was monitored by light microscopy and was 
negligible. In a typical experiment the medium 
trichloroacetic acid-soluble radioactivity rose to 
1644 dpm at trzo (from 0 dpm at to). The total 
radioactivity in the medium at each time point was equal 
to that lost from cells. ‘Latent’ radioactivity [23] was 
never observed 
3.2. Effects of inhibitors on the degradation of 
transplanted B82 karyoplast protein 
The half-life of transplanted B82 nuclear pro- 
teins is 84 * 7 h (table 2b) which is similar to the 
average rate of degradation of all endogenous pro- 
teins in confluent cells (table 2a). The data in table 
2b show that the lysosomotropic inhibitor NH&l 
[ 13,141 inhibits the degradation of transplanted 
nuclear protein by 50%. Leupeptin, an inhibitor of 
lysosomal thiol proteases [ 151, inhibited the 
degradation of transplanted B82 karyoplast pro- 
teins by 30%. 
4. DISCUSSION 
The results in this paper and in [7] show that B82 
karyoplasts prepared by cytochalasin B mediated 
enucleation are successfully transplanted into reci- 
pient B82 cells when Sendai virus is used as a 
fusogen. The 5% whole cells contaminating the 
karyoplast preparation do not make a significant 
contribution to the fusion products (table 1). Mor- 
phological techniques illustrate that the nucleus oc- 
cupies 89% of the karyoplast volume. The 
autoradiographs show that silver grains, i.e. 
radiolabelled protein, are concentrated over the 
transplanted nucleus, and few grains are seen over 
the cytoplasm or the unlabelled nucleus of the 
homokaryon (not shown). Therefore when we 
measure the degradation of transplanted 
karyoplast protein (table 2) it is predominantly the 
degradation of transplanted B82 nuclear proteins 
that is being followed. Since catastrophic destruc- 
tion of nuclei over 140 h did not occur, the 
decrease of cell-associated trichloroacetic acid- 
insoluble radioactivity observed in B82 
homokaryons may represent the normal 
pathway(s) of nuclear protein degradation for 
these multinucleate cells. We do not know whether 
these same pathways are identical with those 
employed by nuclear proteins in mononucleate B82 
cells. 
The effects of both NH&l [ 13,141 and leupeptin 
[15] on lysosomes are well documented. Since 
lysosomes are located exclusively in the cytoplasm 
[ 181 the results suggest that some transplanted 
nuclear proteins, whose degradation is inhibited by 
NH&l and leupeptin, are degraded in lysosomes, 
which implies that they must translocate through 
the nuclear pore (the site for nucleo-cytoplasmic 
167 
Volume 210, number 2 FEBS LETTERS January 1987 
exchange (e.g. [19]) to the cytoplasm before being 
degraded. 
We cannot rule out the possibility that both 
NH&l and leupeptin directly affect nuclear pro- 
teases, although we could measure little or no 
degradation of nuclear proteins in isolated whole 
or disrupted karyoplasts (not shown). The obser- 
vation that two inhibitors of lysosomal protein 
degradation, which act through different 
mechanisms, both inhibit the degradation of some 
transplanted nuclear proteins strongly suggests 
that these proteins are degraded by a lysosomal 
mechanism. Furthermore since non-histone 
chromosomal proteins of mitogen stimulated lym- 
phocytes are degraded by a lysosomal mechanism 
[20-221 it is possible that lysosomes play a hitherto 
unrecognized role in the breakdown of nuclear 
proteins. 
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